CoQ10: Ubiquinol vs Ubiquinone, Statin Depletion, and the Cardiovascular Evidence
Which form of CoQ10 is worth the price premium, who actually needs it, and what the Q-SYMBIO trial means for the rest of us.
By Stack Almanac

Coenzyme Q10 sits at the intersection of cellular energy production and antioxidant defence. Every cell in your body uses it. Your heart muscle, which never stops contracting, has the highest concentration. Production peaks around age 20 and declines steadily after that. By age 80, CoQ10 levels in heart tissue are roughly half what they were at 20.
This decline is not just an academic observation. It correlates with reduced mitochondrial efficiency, increased oxidative stress, and several age-related conditions. The question is whether supplementing with CoQ10 meaningfully reverses any of this, and if so, which form to take and how much.
What CoQ10 does in your body
CoQ10 has two primary roles. First, it is an essential component of the mitochondrial electron transport chain. Specifically, it shuttles electrons between Complex I/II and Complex III during oxidative phosphorylation, the process that produces ATP. Without adequate CoQ10, your mitochondria cannot efficiently convert food into usable energy. Every cell depends on this, but tissues with high energy demands (heart, liver, kidneys, skeletal muscle) are most affected by depletion.
Second, CoQ10 functions as a fat-soluble antioxidant. In its reduced form (ubiquinol), it protects cell membranes and LDL cholesterol from oxidative damage. This is relevant to cardiovascular health because oxidised LDL is more atherogenic than native LDL. CoQ10 is one of the few antioxidants that operates within the lipid bilayer of cell membranes, where most oxidative damage occurs.
Ubiquinone vs ubiquinol: the form debate
CoQ10 exists in two forms that your body constantly converts between. Understanding both matters because the supplement market treats them as fundamentally different products with different price tags.
Ubiquinone (oxidised form)
The traditional supplement form. It is more stable, less expensive, and has a longer track record in clinical research. Most of the landmark CoQ10 trials used ubiquinone. After absorption, your body converts ubiquinone to ubiquinol in the gut wall, liver, and bloodstream. In healthy individuals under 40, this conversion is efficient.
Ubiquinol (reduced form)
The 'active' or 'pre-converted' form. It does not require the reduction step before your body can use it as an antioxidant. It is less stable (requires special manufacturing to prevent oxidation) and more expensive, typically 2 to 3 times the price of ubiquinone at equivalent doses.
The marketing pitch is straightforward: ubiquinol is the active form, so why make your body do the conversion? This logic has some validity for specific populations but is oversimplified for most people.
Who benefits from ubiquinol specifically
The conversion from ubiquinone to ubiquinol depends on enzymes (NADH and NADPH-dependent reductases) whose activity declines with age and certain health conditions. Ubiquinol may offer a meaningful advantage for:
- Adults over 50 to 60. Age-related decline in reductase activity makes the conversion less efficient. Blood levels of CoQ10 after ubiquinol supplementation tend to be higher in older adults compared to equivalent doses of ubiquinone.
- People with heart failure. Impaired CoQ10 metabolism is common in heart failure. The Q-SYMBIO trial (discussed below) used ubiquinone, but subsequent pharmacokinetic studies suggest ubiquinol achieves higher plasma levels in this population.
- People on statins. Statins inhibit the mevalonate pathway, which produces both cholesterol and CoQ10. The resulting depletion may impair the conversion step as well, making pre-reduced ubiquinol a more direct route.
For healthy adults under 40 to 50, the practical difference between the two forms is small. Ubiquinone is a reasonable, cost-effective choice. The conversion works fine in this population, and the price difference is hard to justify based on current evidence.
Statin-induced CoQ10 depletion
Statins are among the most prescribed medications worldwide. They work by inhibiting HMG-CoA reductase, the enzyme that controls cholesterol synthesis. The problem: CoQ10 is synthesized through the same mevalonate pathway that statins block. Statin use reduces circulating CoQ10 levels by 20 to 40% in most studies.
Whether this depletion causes symptoms is debated, but the pattern is consistent. Statin-related muscle pain (myalgia) affects 5 to 15% of users. Several mechanisms have been proposed, and mitochondrial dysfunction from CoQ10 depletion is one of them. A 2018 meta-analysis of 12 RCTs found that CoQ10 supplementation reduced statin-associated muscle symptoms, though the effect size was modest and study quality varied.
The practical guidance: if you take a statin and experience muscle pain or fatigue, a trial of CoQ10 at 100 to 200 mg daily for 8 to 12 weeks is reasonable. This is not a guaranteed fix. Some statin myalgia has nothing to do with CoQ10. We are not going to tell you the risk is zero, because nobody can. CoQ10 has no authorised wording on the GB nutrition and health claims register, and anything taken alongside a statin is a question for the prescriber or pharmacist who manages that statin. Raise it with them before you add it.
Cardiovascular evidence: the Q-SYMBIO trial
The most significant CoQ10 cardiovascular trial is Q-SYMBIO, published in 2014 in JACC Heart Failure. It randomized 420 patients with moderate-to-severe heart failure to either 100 mg of CoQ10 (ubiquinone) three times daily (300 mg total) or placebo, on top of standard heart failure treatment, for two years.
The results were striking. The CoQ10 group had a 43% reduction in cardiovascular mortality, a 42% reduction in all-cause mortality, and significant improvements in NYHA functional class. These are large effect sizes for an add-on supplement in a well-treated heart failure population.
Important context: Q-SYMBIO was a single trial, albeit well-designed and adequately powered. The cardiology community has been cautious about embracing CoQ10 based on one trial, even a good one. Replication is needed. But the signal is strong enough that the European Society of Cardiology's 2021 guidelines mention CoQ10 as a potential adjunctive therapy in heart failure, and several ongoing trials are testing it further.
This is not evidence that CoQ10 prevents heart disease in healthy people. Q-SYMBIO enrolled patients with established heart failure. Extrapolating to primary prevention is not supported by the data.
Other evidence areas
Migraine prevention
A 2021 meta-analysis of five RCTs found that CoQ10 supplementation (100 to 300 mg daily) reduced migraine frequency by roughly 1.5 attacks per month compared to placebo. The effect took 4 to 12 weeks to emerge. This is comparable to some prescription preventive medications, with a much milder side effect profile. The American Headache Society lists CoQ10 as a Level B recommendation (probably effective) for migraine prevention.
Exercise performance
Evidence for CoQ10 improving athletic performance in healthy young people is weak. Most well-designed trials show no significant effect on VO2 max, power output, or recovery in trained athletes. Where CoQ10 may help is in older adults or those with baseline CoQ10 depletion, where energy production is already compromised. Do not expect performance enhancement if you are young and healthy.
Fertility
Emerging evidence suggests CoQ10 may improve egg quality in women over 35 undergoing IVF, potentially by supporting mitochondrial function in oocytes. A 2018 RCT found improved ovarian response and embryo quality with 600 mg daily pre-treatment. The evidence base is still small, and doses used are higher than for other indications.
Dose ranges
- General supplementation: 100 to 200 mg daily. This is sufficient to raise blood levels meaningfully in most people and covers the range used in statin depletion studies.
- Heart failure (adjunctive): 300 mg daily (100 mg three times), based on Q-SYMBIO. This dose should only be used under medical supervision alongside standard heart failure treatment.
- Migraine prevention: 100 to 300 mg daily, with 4 to 12 weeks needed to assess response.
- Fertility trials: the published trials used 200 to 600 mg daily, and there are few of them. Fertility treatment is clinical care, so that number belongs in a conversation with your fertility specialist rather than on a shopping list.
CoQ10 is fat-soluble. Take it with a meal containing fat for better absorption. Splitting the dose (morning and evening with meals) may improve blood levels compared to a single daily dose, particularly at 200 mg and above.
Safety and interactions
CoQ10 has an excellent safety profile. Side effects in clinical trials are rare and mild: occasional GI discomfort, usually resolving within a few days. Doses up to 1200 mg daily have been used in Parkinson's disease trials without significant adverse effects.
One meaningful interaction: CoQ10 shares structural similarity with vitamin K and may reduce the effectiveness of warfarin. If you take warfarin, consult your prescriber before starting CoQ10. This interaction does not apply to direct oral anticoagulants (DOACs) like apixaban or rivarfarin.
Whether to take CoQ10 alongside a statin is a question for the prescriber or pharmacist who manages the statin, and they can see your full medicines list. We are not in a position to tell you it is fine, and a blog post is not where that decision belongs.
How Stack Almanac handles this
Stack Almanac holds reference information on CoQ10 and the medicines it has been studied alongside, statins included, with the sources behind each one. It does not read your prescription list and tell you to add something. The ubiquinol and ubiquinone difference, the conversion question and the amounts each trial used are all on the ingredient page, with the price difference in plain view. Check with your pharmacist.
The CoQ10 and warfarin interaction is in that reference material with its source, because it is one of the better documented ones. Nothing alerts you about your own prescription, and nothing rates your amount against a goal. Your record holds the amount you took, dated, and the trial amounts sit next to it for you to compare. Anyone on warfarin should raise it with their anticoagulant clinic first.
Frequently asked questions
Related reading
Mentioned a supplement you want to learn more about? Browse our ingredient reference for UK reference values, forms, timing and pairings.
Check this across your whole routine
Paste the supplements you take. The free check adds up the totals, shows where products overlap, shows general timing information and works out monthly spend, before you create an account.
Audit your supplement routineOccasional field notes
Useful reading, when we have it.
New evidence guides and meaningful product updates. No daily drip, no supplement sales pitch.